MiNK Therapeutics Inc.
July 11, 2025 - by Joey Ramson
$INKT is hyperbolic today as it was announced that there was a complete remission in a patient with metastatic testicular cancer following treatment with the company’s allogeneic iNKT cell therapy, agenT-797
